Effect of exercise training in patients with heart failure: A pilot study on autonomic balance assessed by heart rate variability

European Journal of Preventive Cardiology

Volumn 11, Issue 2, 2004, Pages 162-167

  Larsen, Alf Inge ^a   Gjesdal, Knut ^b   Hall, Christian ^c   Aukrust, PãƒÂ¥l ^c   Aarsland, TorbjãƒÂ¸rn ^d   Dickstein, Kenneth ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d Hjertelaget Research Foundation   (Norway)

Author keywords

atrial natriuretic peptide; exercise training; heart failure; heart rate variability

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CORRELATION ANALYSIS; EVALUATION; EXERCISE; HEART FAILURE; HEART FUNCTION TEST; HEART RATE; HEART RATE VARIABILITY; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

EID: 2342508981     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000124214.21584.bb     Document Type: Article

References (26)

1. Makikallio TH, Huikuri HV, Hintze U, Videback J, Mitrani RD, Castellanos A, et al. Fractal analysis and time- and frequency-domain measures of heart rate variability as predictors of mortality in patients with heart failure. Am J Cardiol 2001; 87: 178–182.
2. Galinier M, Pathak A, Fourcade J, Androdias C, Curnier D, Varnous S, et al. Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure. Eur Heart J 2000; 21: 475–482.
3. Huikuri HV, Makikallio T, Airaksinen KE, Mitrani R, Castellanos A, Myerburg RJ. Measurement of heart rate variability: a clinical tool or a research toy? J Am Coll Cardiol 1999; 34: 1878–1883.
4. Yoshikawa T, Baba A, Akaishi M, Miramura H, Ogawa S, Suzuki M, et al. Neurohumoral activations in congestive heart failure: correlations with cardiac function, heart rate variability, and baroreceptor sensitivity. Am Heart J 1999; 137: 666–671.
5. Radaelli A, Coats AJ, Leuzzi S, Piepoli M, Meyer TE, Calciati A, et al. Physical training enhances sympathetic and parasympathetic control of heart rate and peripheral vessels in chronic heart failure. Clin Sci (Colch) 1996; 91(Suppl 2):92–94.
6. Kiilavuori K, Toivonen L, Naveri H, Leinonen H. Reversal of autonomic derangements by physical training in chronic heart failure assessed by heart rate variability. Eur Heart J 1995; 16: 490–495.
7. Morris JN, Clayton DG, Everitt MG, Semmence AM, Burgess EH. Exercise in leisure time: coronary attacks and death rates. Br Heart J 1990; 63: 325–334.
8. Coats AJS, Adamopoulos S, Radaelli A, McCance A, Meyer TE, Bernardi C. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation and autonomic function. Circulation 1992; 85: 2119–2131.
9. Larsen AI, Aarsland T, Haugland A, Kristiansen M, Dickstein K. Assessing the effect of exercise training in men with heart failure. Comparison of maximal, submaximal and endurance exercise protocols. Eur Heart J 2001; 22: 684–692.
10. Riley M, McParland J, Stanford C, Nicholls DP. Oxygen consumption during corridor walk testing in chronic cardiac failure. Eur Heart J 1992; 13: 789–793.
11. Sundsfjord JA, Thibault G, Larochelle P, Cantin M. Identification and plasma concentrations of N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab 1988; 66: 605–610.
12. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology 1996.
13. Eckberg DL. Sympathovagal balance: a critical appraisal. Circulation 1997; 96: 3224–3232.
14. Larsen AI, Aukrust P, Aarsland T, Dickstein K. Effect of aerobic exercise training on plasma levels of tumor necrosis factor alpha in patients with heart failure. Am J Cardiol 2001; 88: 805–808.
15. Larsen AI, Hall C, Aukrust P, Aarsland T, Faris P, Dickstein K. Prognostic usefulness of an increase of N-terminal Proatrial Natriuretic Peptide during exercise in patients with chronic heart failure. Am J Cardiol 2003; 92: 91–94.
16. Tygesen H, Rundqvist B, Waagstein F, Wennerblom B. Heart rate variability measurement correlates with cardiac norepinephrine spillover in congestive heart failure. Am J Cardiol 2001; 87: 1308–1311.
17. Ponikowski PP, Chua TP, Francis DP, Capucci A, Coats AJ, Piepoli MF. Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. Circulation 2001; 104: 2324–2330.
18. Adamopoulos S, Coats AJ, Brunotte F, Arnolda L, Meyer T, Thompson CH, et al. Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol 1993; 21: 1101–1106.
19. Floras JS. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol 1993; 4(Suppl A):72A–84A.
20. Ponikowski P, Chua TP, Amadi AA, Piepoli M, Harrington D, Volterrani M, et al. Detection and significance of a discrete very low frequency rhythm in RR-interval variability in chronic congestive heart failure. Am J Cardiol 1996; 77: 1320–1326.
21. Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, et al. Prospective study of heart rate variability and mortality in chronic heart failure. Circulation 1998; 98: 1510–1516.
22. Boveda S, Galinier M, Pathak A, Fourcade J, Dongay B, Benchendikh D, et al. Prognostic value of heart rate variability in time domain analysis in congestive heart failure. J Interv Card Electrophysiol 2001; 5: 181–187.
23. Tuininga YS, van Veldhuisen DJ, Brouwer J, Haaksma J, Crijns HJ, Manint Veld AJ, et al. Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment. Br Heart J 1994; 72: 509–513.
24. Otterstad JE, Ford I. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials? Eur J Heart Failure 2002; 4: 501–506.
25. Horner SM, Murphy CF, Cohen B, Dick DJ, Harrison FG, Vespalcova Z, et al. Contribution to heart rate variability by mechanoelectric feedback. Circulation 1996; 94: 1762–1767.
26. Aronson D, Mittleman MA, Burger AJ. Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J Cardiovasc Electrophysiol 2001; 12: 294–300.